Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction (Sweetheart)

September 7, 2010 updated by: Stiftung Institut fuer Herzinfarktforschung

Sweetheart: Risiko-Management Von Diabetikern Mit Akutem Myokardinfarkt

The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

2772

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • München, Germany, 80804
        • Städ Krankenhaus münchen Schwabing
      • Nürnberg, Germany, 90471
        • Klinikum Nürnberg Süd /Cardiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction or acute (no older than 24 h) Non-ST-Elevation Myocardial infarction.

Description

Inclusion Criteria:

  • consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction
  • consecutive patients with acute (no older than 24 h) Non-ST-Elevation Myocardial infarction

Exclusion Criteria:

  • missing informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Documentation of the characteristics consecutive patients with acute STEMI or NSTEMI in daily hospital routine in Germany
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009

Secondary Outcome Measures

Outcome Measure
Time Frame
Documentation of the fraction of patients with (I) a previous know Diabetes Mellitus (DM) type I and II, (II) a newly diagnosed DM, (III) diagnosed with IFG or IGT for the first time
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009
Documentation of acute invasive and adjuvant medicamentous therapy of STEMI and NSREMI in hospital daily routine in Germany
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009
Documentation of diabetic therapy during the acute phase of a myocardial infarction
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009
Documentation of the hospital mortality, the serious but non-fatal complications (stroke, re-myocardial infarction) and other bleeding complications
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009
Verification of the implementation of a therapy according to the guidelines for STEMI / NSTEMI in daily hospital routine
Time Frame: 04/01/2007-09/30/2009
04/01/2007-09/30/2009

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stiftung Institut fuer Herzinfarktforschung

Collaborators

Sanofi-Aventis Deutschland GmbH

Investigators

  • Study Chair: Anselm K Gitt, MD, Stiftung Institut für Herzinfarktforschung
  • Study Chair: Jochen Senges, MD, Stiftung Institut für Herzinfarktforschung

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2007

Study Completion (Actual)

September 1, 2009

Study Registration Dates

First Submitted

September 7, 2010

First Submitted That Met QC Criteria

September 7, 2010

First Posted (Estimate)

September 9, 2010

Study Record Updates

Last Update Posted (Estimate)

September 9, 2010

Last Update Submitted That Met QC Criteria

September 7, 2010

Last Verified

September 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Sweetheart

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe